Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: A Comparison of Telmisartan + Hydrochlorothiazide With Amlodipine + Hydrochlorothiazide in the Control of Blood Pressure in Older Patients With Predominantly Systolic Hypertension (ATHOS Study) [Phase 4]
Phase 4 ATHOS study comparing telmisartan/hydrochlorothiazide with amlodipine/hydrochlorothiazide for blood pressure control in older patien…
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: Prospective Randomised Investigation of the Safety and Efficacy of Micardis® vs Ramipril Using ABPM [Phase 4]
A Phase 4 randomized trial comparing Micardis (telmisartan) to ramipril in hypertension using ambulatory blood pressure monitoring to assess…
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: DETAIL Study: Diabetes Exposed to Telmisartan and Enalapril [Phase 3]
Phase 3 DETAIL trial evaluating exposure to telmisartan and enalapril in patients with hypertension and type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: Telmisartan vs. Valsartan in Patients With Mild to Moderate Hypertension Following a Missed Dose [Phase 4]
This Phase 4 trial compares telmisartan to valsartan in adults with mild to moderate hypertension after a missed dose and has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: Inflammation and Coronary Artery Disease: Role of AT1-Receptor Antagonism [Phase 4]
A Phase 4 trial sponsored by Boehringer Ingelheim evaluated AT1-receptor antagonism in inflammation related to hypertension and coronary art…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-10-31Clinical Trial Update: Pharmacist-Physician Collaborative Medication Therapy Management Services (MTMS) Demonstration Project [NA]
Completed demonstration project evaluating pharmacist-physician collaborative medication therapy management services for hypertension.
-
CLINICAL_TRIALS trial_result · 2013-10-30Clinical Trial Update: New Angiotensin II Receptor Blocker Azilsartan Study for Stronger Blood Pressure Lowering [Phase 4]
Phase 4 clinical trial update on azilsartan for stronger blood pressure lowering in hypertension; the study has completed.
-
CLINICAL_TRIALS trial_result · 2013-10-30Clinical Trial Update: A Pilot Study to Evaluate Efficacy and Safety of Clevidipine in Neurosurgical Patients [Phase 4]
Phase 4 pilot trial evaluating the efficacy and safety of clevidipine in neurosurgical patients. The study status is Completed with results …
-
CLINICAL_TRIALS trial_result · 2013-10-30Clinical Trial Update: Angiotensin II Receptor Blockers (ARB) and ACE Inhibitors (ACEI) on Silent Brain Infarction and Cognitive Decline [Phase 4]
A Phase 4 clinical trial evaluated the effects of angiotensin II receptor blockers and ACE inhibitors on silent brain infarction and cogniti…
-
FDA approval · 2013-10-29FDA Approved: CLONIDINE — Original Application (XGen Pharmaceuticals DJB, Inc.)
FDA approved a generic clonidine product from XGen Pharmaceuticals DJB, Inc. under an Original ANDA submission.
-
FDA approval · 2013-10-29FDA Approved: LISINOPRIL — Original Application (Exelan Pharmaceuticals Inc.)
FDA approved Exelan Pharmaceuticals’ Original Application for lisinopril, a generic ACE inhibitor, marking the availability of a generic lis…
-
CLINICAL_TRIALS trial_result · 2013-10-28Clinical Trial Update: The Second Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial [NA]
Completed clinical trial evaluating intensive blood pressure reduction in acute intracerebral hemorrhage, with results posted in 2013.
-
CLINICAL_TRIALS research · 2013-10-25Clinical Trial Update: A Phase Ⅲ Study of Extended-Release Carvedilol Sulfate for the Treatment of Hypertension [Phase 3]
A Phase 3 clinical trial evaluating an extended-release carvedilol sulfate formulation for hypertension; the current status of the study is …
-
CLINICAL_TRIALS trial_result · 2013-10-24Clinical Trial Update: Effects of Aliskiren and Amlodipine on the Renin-Angiotensin System (RAS) and Lipid/Carbohydrate Metabolism in Obese Patients With Hypertension [Phase 2]
Phase 2 clinical trial evaluating the effects of aliskiren and amlodipine on the renin-angiotensin system and lipid/carbohydrate metabolism …
-
CLINICAL_TRIALS trial_result · 2013-10-22Clinical Trial Update: To Evaluate the Pharmacokinetic Interactions and Safety Between Fimasartan and Rosuvastatin [Phase 1]
Phase 1 study evaluating the pharmacokinetic interactions and safety of combining fimasartan with rosuvastatin.
-
FDA approval · 2013-10-18FDA Approved: DIOVAN — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Diovan (valsartan) submitted by Novartis Pharmaceuticals Corporation.
-
CLINICAL_TRIALS trial_result · 2013-10-16Clinical Trial Update: Effects of a Resistance Training Period on Blood Pressure of Hypertensive Elderlies: Influence of the Polymorphism of the Angiotensin Converting Enzyme [NA]
This completed clinical trial evaluated whether a period of resistance training affects blood pressure in hypertensive elderly individuals a…
-
CLINICAL_TRIALS research · 2013-10-16Clinical Trial Update: Increased Activity of a Renal Salt Transporter (ENaC) in Diabetic Kidney Disease [NA]
This trial update investigates increased activity of the renal ENaC transporter in diabetic nephropathy, with relevance to hypertension.
-
CLINICAL_TRIALS trial_result · 2013-10-11Clinical Trial Update: The Effect of Olive Leaf Extract on Blood Pressure in Overweight Prehypertensives [NA]
A completed clinical trial evaluated the effect of olive leaf extract on blood pressure in overweight individuals with prehypertension.
-
CLINICAL_TRIALS trial_result · 2013-10-09Clinical Trial Update: Combined Treatment of Arterial Hypertension and Atrial Fibrillation [Phase 2]
Phase 2 clinical trial evaluating a combined treatment approach for hypertension and atrial fibrillation has completed.
-
CLINICAL_TRIALS withdrawal · 2013-10-01Clinical Trial Update: A Novel Non-interfering Arterial Blood Pressure Monitoring Device [NA]
A clinical trial evaluating Sense A/S's novel non-interfering arterial blood pressure monitoring device has been withdrawn. The study involv…
-
CLINICAL_TRIALS trial_result · 2013-09-27Clinical Trial Update: Effect of a Secure Message Reminder on Hypertension Follow-up at an Integrated Health Care System [NA]
A completed Kaiser Permanente clinical trial evaluated whether secure message reminders improve hypertension follow-up within an integrated …
-
CLINICAL_TRIALS research · 2013-09-26Clinical Trial Update: Abuja Heart Study: Prospective Epidemiological Investigation of Cardiovascular Diseases
An update on the Abuja Heart Study, a prospective epidemiological investigation of cardiovascular diseases and hypertension.
-
FDA label_change · 2013-09-20FDA Approved: BYSTOLIC — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for Bystolic (nebivolol hydrochloride) submitted by Allergan, Inc., resulting in labeling updates fo…
-
CLINICAL_TRIALS trial_result · 2013-09-19Clinical Trial Update: Diuretics, Hypertension, and Arrhythmias Clinical Trial [Phase 3]
A Phase 3 clinical trial from UCSF evaluating diuretics for hypertension and arrhythmias has completed. The snippet does not provide trial r…